Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800909901> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2800909901 endingPage "227" @default.
- W2800909901 startingPage "223" @default.
- W2800909901 abstract "Background: overactive bladder (OAB) also referred to as the urgency-frequency syndrome, with or without urge urinary incontinence can considerably impair the patient's quality of life. It is widely accepted that diet and life style modifications, behavioral therapy and medication belong to the standard conservative therapeutic options and considered as the first-line measures. The International Consultation on Incontinence (ICI) guidelines reported that when the first line approach is not fully satisfactory or fails after 8-12 weeks, alternative therapies should be sought out. It is worthwhile and justified to proceed to second-line therapy if patients are refractory to antimuscarinic therapy or if the treatment is contraindicated. Second-line of therapies include less-invasive measures such as percutaneous posterior tibial neve stimulation, sacral neuromodulation, detrusor injections with botulinum toxin (BTX) and whereas more-invasive measures constitute surgical techniques e.g. bladder augmentation or substitution. Pelvic neuromodulation has been proven effective and is today an established treatment option for patients refractory to or intolerant of conservative treatments.Objective: this study aimed to compare between the efficacy of continuous anticholinergic therapy and intermitted anticholinergic therapy for treatment of the overactive bladder.Patients and Methods: our study included 60 patients categorized into two groups: continuous anticholinergic therapy group and intermitted anticholinergic therapy. By using 12 weekly intermitted anticholinergic therapies, remarkable clinical results were obtained. Percent of the patients who complained OAB in the intermitted anticholinergic group reported a statistically significant subjective success. These patients chose to continue treatment to maintain the response.Results: patients in the intermitted anticholinergic therapy group showed significant improvement of frequency (31%) urgency (50%) urge incontinence (50%) and nocturia (53%) compared to propiverine group frequency (50%) urgency (60%) urge incontinence (67%) and nocturia (67%). No serious side effects were reported, in group A 8 patients had horm of dry mouth in 5 cases (16.7%), constipation in 2 cases (67%) 8 blurred vision in one case (33%). In group B, there were 5 patients (16.7%) in the horm of dry mouth in 3 cases (10% constipation in one case (3.3) and blurred vision in one case (3.3%).Conclusion: our study concluded that intermittent anticholinergic therapy induced improvement of bladder over activity symptoms and less side effects than continuous anticholinergic group." @default.
- W2800909901 created "2018-05-17" @default.
- W2800909901 creator A5025929527 @default.
- W2800909901 creator A5057640548 @default.
- W2800909901 creator A5074765027 @default.
- W2800909901 date "2018-01-01" @default.
- W2800909901 modified "2023-10-16" @default.
- W2800909901 title "Safety and Efficacy of Intermittent versus Continuous Anticholinergic Medication in Management of Overactive Bladder in Adult" @default.
- W2800909901 cites W2064471798 @default.
- W2800909901 doi "https://doi.org/10.12816/0043080" @default.
- W2800909901 hasPublicationYear "2018" @default.
- W2800909901 type Work @default.
- W2800909901 sameAs 2800909901 @default.
- W2800909901 citedByCount "2" @default.
- W2800909901 countsByYear W28009099012021 @default.
- W2800909901 countsByYear W28009099012022 @default.
- W2800909901 crossrefType "journal-article" @default.
- W2800909901 hasAuthorship W2800909901A5025929527 @default.
- W2800909901 hasAuthorship W2800909901A5057640548 @default.
- W2800909901 hasAuthorship W2800909901A5074765027 @default.
- W2800909901 hasConcept C121332964 @default.
- W2800909901 hasConcept C126322002 @default.
- W2800909901 hasConcept C126894567 @default.
- W2800909901 hasConcept C142424586 @default.
- W2800909901 hasConcept C142724271 @default.
- W2800909901 hasConcept C204787440 @default.
- W2800909901 hasConcept C24998067 @default.
- W2800909901 hasConcept C2777844464 @default.
- W2800909901 hasConcept C2778531004 @default.
- W2800909901 hasConcept C2778689640 @default.
- W2800909901 hasConcept C2778941218 @default.
- W2800909901 hasConcept C2780375056 @default.
- W2800909901 hasConcept C2910745098 @default.
- W2800909901 hasConcept C42219234 @default.
- W2800909901 hasConcept C71924100 @default.
- W2800909901 hasConcept C87355193 @default.
- W2800909901 hasConceptScore W2800909901C121332964 @default.
- W2800909901 hasConceptScore W2800909901C126322002 @default.
- W2800909901 hasConceptScore W2800909901C126894567 @default.
- W2800909901 hasConceptScore W2800909901C142424586 @default.
- W2800909901 hasConceptScore W2800909901C142724271 @default.
- W2800909901 hasConceptScore W2800909901C204787440 @default.
- W2800909901 hasConceptScore W2800909901C24998067 @default.
- W2800909901 hasConceptScore W2800909901C2777844464 @default.
- W2800909901 hasConceptScore W2800909901C2778531004 @default.
- W2800909901 hasConceptScore W2800909901C2778689640 @default.
- W2800909901 hasConceptScore W2800909901C2778941218 @default.
- W2800909901 hasConceptScore W2800909901C2780375056 @default.
- W2800909901 hasConceptScore W2800909901C2910745098 @default.
- W2800909901 hasConceptScore W2800909901C42219234 @default.
- W2800909901 hasConceptScore W2800909901C71924100 @default.
- W2800909901 hasConceptScore W2800909901C87355193 @default.
- W2800909901 hasIssue "2" @default.
- W2800909901 hasLocation W28009099011 @default.
- W2800909901 hasOpenAccess W2800909901 @default.
- W2800909901 hasPrimaryLocation W28009099011 @default.
- W2800909901 hasRelatedWork W134550863 @default.
- W2800909901 hasRelatedWork W1507298952 @default.
- W2800909901 hasRelatedWork W2009397625 @default.
- W2800909901 hasRelatedWork W2012618608 @default.
- W2800909901 hasRelatedWork W2079287622 @default.
- W2800909901 hasRelatedWork W2081386520 @default.
- W2800909901 hasRelatedWork W2096097517 @default.
- W2800909901 hasRelatedWork W2753430759 @default.
- W2800909901 hasRelatedWork W2788655079 @default.
- W2800909901 hasRelatedWork W3025416379 @default.
- W2800909901 hasVolume "70" @default.
- W2800909901 isParatext "false" @default.
- W2800909901 isRetracted "false" @default.
- W2800909901 magId "2800909901" @default.
- W2800909901 workType "article" @default.